Danya Institute Inc.

NIDA Announces New Opioid Tx ED Resources

From NIDA.

New opioid treatment resources for emergency department clinicians

Announcement | October 03, 2018

The National Institute on Drug Abuse (NIDA) today announced the availability of informational resources for clinicians interested in initiating buprenorphine treatment in emergency department settings. Buprenorphine is one of several medicines available for use in many emergency departments to treat opioid use disorders (OUD). The materials were developed by emergency department specialists at Yale University with grant support from NIDA, and contract support from NIDA’s Clinical Trials Network. NIDA is part of the National Institutes of Health.

Emergency department clinicians face unique challenges when faced with patients suffering from opioid overdoses or other effects of OUD. They can often reverse overdoses using the medication naloxone, however, that medication alone does not constitute treatment for the addiction itself. This makes the emergency setting an ideal place for clinicians to begin treatment conversations with patients, however, there have been few tools available to guide them. Since 2002, emergency clinicians have been able to administer buprenorphine to help patients manage opioid withdrawal symptoms, but the practice is still new in many emergency department settings.

NIDA has funded research into the initiation of medication for OUD in the emergency setting, with findings reflected in these new resources. This new comprehensive set of tools includes information on best practices as well as case-based videos to provide emergency department clinicians with effective strategies and conversation tips to treat people with opioid use disorders. These new informational resources, which specifically highlight buprenorphine treatment, are now provided as a courtesy on the NIDAMED web portal, and do not constitute official clinical guidelines or standards.  The NIDAMED web portal disseminates science-based resources to health professionals on the causes and consequences of drug use and addiction, and advances in pain management.

Highlights of the tools and resources now available include:

View original announcement.